Aging restricts the ability of mesenchymal stem cells to promote the generation of oligodendrocytes during remyelination-Reference-Cited by-同舟云学术

Aging restricts the ability of mesenchymal stem cells to promote the generation of oligodendrocytes during remyelination

Published:2019-04-30 Issue: Volume: Page:
ISSN:0894-1491
Container-title:Glia
language:en
Short-container-title:Glia

Author:

Rivera Francisco J.¹²³⁴⁵^ORCID,Fuente Alerie G.⁵^ORCID,Zhao Chao⁵^ORCID,Silva Maria E.¹²³⁴⁵^ORCID,Gonzalez Ginez A.⁵^ORCID,Wodnar Roman³⁴,Feichtner Martina³⁴,Lange Simona³⁴,Errea Oihana⁵,Priglinger Eleni³⁶⁷^ORCID,O'Sullivan Anna³⁴⁸,Romanelli Pasquale⁴⁸^ORCID,Jadasz Janusz J.⁹^ORCID,Brachtl Gabriele¹⁰¹¹,Greil Richard¹⁰,Tempfer Herbert⁴⁷¹²,Traweger Andreas⁴⁷¹²^ORCID,Bátiz Luis F.²¹³^ORCID,Küry Patrick¹⁴^ORCID,Couillard‐Despres Sebastien⁴⁷⁸^ORCID,Franklin Robin J. M.⁵^ORCID,Aigner Ludwig³⁴⁷^ORCID

Affiliation:

1. Laboratory of Stem Cells and Neuroregeneration, Institute of Anatomy, Histology and PathologyFaculty of Medicine, Universidad Austral de Chile Valdivia Chile

2. Center for Interdisciplinary Studies on the Nervous System (CISNe)Universidad Austral de Chile Valdivia Chile

3. Institute of Molecular Regenerative MedicineParacelsus Medical University Salzburg Austria

4. Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI‐TReCS)Paracelsus Medical University Salzburg Austria

5. Wellcome‐MRC Cambridge Stem Cell Institute & Department of Clinical NeurosciencesUniversity of Cambridge Cambridge UK

6. Ludwig Boltzmann Institute for Experimental and Clinical TraumatologyAUVA Research Center Linz/Vienna Austria

7. Austrian Cluster for Tissue Regeneration Vienna Austria

8. Institute of Experimental NeuroregenerationParacelsus Medical University Salzburg Salzburg Austria

9. Laboratory of Experimental Ophthalmology, Department of OphthalmologyUniversity Hospital Düsseldorf, Heinrich‐Heine‐University Düsseldorf Germany

10. Laboratory for Immunological and Molecular Cancer Research, 3rd Medical Department for Hematology, Medical Oncology, Hemostasiology, Infectious Diseases, and RheumatologyFederal Hospital of Salzburg and Paracelsus Medical University Salzburg Austria

11. Experimental and Clinical Cell Therapy InstituteParacelsus Medical University Salzburg Austria

12. Institute of Tendon and Bone RegenerationParacelsus Medical University Salzburg Austria

13. Centro de Investigación Biomédica (CIB), Facultad de MedicinaUniversidad de los Andes Santiago Chile

14. Department of Neurology, Medical FacultyHeinrich‐Heine‐University Düsseldorf Germany

Funder

Dr. Miriam and Sheldon G. Adelson Medical Research Foundation

Bundesministerium für Bildung und Forschung

Comisión Nacional de Investigación Científica y Tecnológica

Deutsche Forschungsgemeinschaft

Medical Research Council Canada

Wellcome Trust

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/glia.23624

Reference40 articles.

1. Aging alters tissue resident mesenchymal stem cell properties

2. Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models

3. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis

4. Study of Telomere Length Reveals Rapid Aging of Human Marrow Stromal Cells following In Vitro Expansion

5. Lysolecithin induces demyelination in vitro in a cerebellar slice culture system

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sox2-mediated transdifferentiation of hAT-MSCs into induced neural progenitor-like cells for remyelination therapies;Tissue and Cell;2024-12

2. Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosis;Journal of Neurology;2024-08-23

3. Role of Mesenchymal Stem/Stromal Cells in Head and Neck Cancer—Regulatory Mechanisms of Tumorigenic and Immune Activity, Chemotherapy Resistance, and Therapeutic Benefits of Stromal Cell-Based Pharmacological Strategies;Cells;2024-07-28

4. Mesenchymal stromal cell-derived secretome-based therapy for neurodegenerative diseases: overview of clinical trials;Stem Cell Research & Therapy;2023-05-04

5. Ocrelizumab in pediatric multiple sclerosis;European Journal of Paediatric Neurology;2023-03